Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa InhibitorsStuart J. Connolly, Truman J. Milling, Andrew M. Demchuk et al.|New England Journal of Medicine|2019Cited by 945
Enoxaparin versus Unfractionated Heparin with Fibrinolysis for ST-Elevation Myocardial InfarctionElliott M. Antman, Eugene Braunwald, David A. Morrow et al.|New England Journal of Medicine|2006Cited by 605
Classification, prevalence, and outcomes of anticancer therapy-induced cardiotoxicity: the CARDIOTOX registryJosé López‐Sendón, Teresa López‐Fernández, Carlos Álvarez-Ortega et al.|European Heart Journal|2020Cited by 282
Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trialJean‐Claude Tardif, Guy Boivin, Nadia Bouabdallaoui et al.|The Lancet Respiratory Medicine|2021Cited by 271
Final Study Report of Andexanet Alfa for Major Bleeding With Factor Xa InhibitorsTruman J. Milling, Rainer Dziewas, Saskia Middeldorp et al.|Circulation|2023Cited by 153